What is the bioequivalence test?
The bioequivalence test consists of demonstrating that the generic drug and its respective reference drug (that for which clinical research was carried out to prove its effectiveness and safety before being registered) present the same bioavailability in the organism. Bioequivalence, in the great majority of cases, ensures that the generic drug is the therapeutic equivalent of the reference drug (ie: that which has the same clinical effectiveness and the safety level as the reference drug).
